RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $127.76
Change $0.04 | 0.03%
As Of 8/20/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.


Net Asset Value

Net Asset Value $127.76
Change $0.04 | 0.03%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Profile

Volume 13,035
Last Sale Price $127.75
52-Week Range $127.76 / $96.60
Shares Outstanding 2,400,000
Total Net Assets $306,622,312.41

Overall Morningstar RatingTM *

as of 3/31/14

Among Health Funds

The Fund was rated, based on its risk-adjusted returns, 3 stars for 3 years, 4 stars for 5 years, and 4 stars Overall out of 19, 17 and 19 Health funds, respectively.

Market Close

Market Price $127.75
Premium / Discount -$0.01
Change $0.02 | 0.02%
High / Low $127.95 / $127.29


Historical Market Closes to NAV

  Days % of Total Days
Premium 955 48.67%
Discount 899 45.82%
Equal to NAV 108 5.50%
Total 1,962 100%


Characteristics

Number of Stocks 54
Return on Equity (quarterly 6/30/14) 17.58%
Price to Earning (P/E) 24.49
Price to Book (P/B) 3.59
Dividend Amount $0.17
Ex-Dividend Date N/A

Risk

As of 7/31/14
Standard Deviation Sharpe Ratio Beta R-Squared
12.08 1.85 1.02 99.50

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.

Overview

as of 8/20/2014
Total Assets $306,622,312
Number of Stocks 54
Percent Stock 99.86%
Percent Cash / Other 0.14%

Sectors / Industries

as of 8/20/14

Holdings

as of 8/20/14

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
TENET HEALTHCARE CORP THC 114,196 $6,868,889.40 2.24% Health Care Providers & Services
GILEAD SCIENCES, INC. GILD 66,449 $6,697,394.71 2.18% Biotechnology
EDWARDS LIFESCIENCES CORP EW 68,437 $6,677,398.09 2.18% Health Care Equipment & Supplies
VERTEX PHARMACEUTICALS VRTX 72,978 $6,662,891.40 2.17% Biotechnology
COVIDIEN PLC COV 74,456 $6,610,948.24 2.16% Health Care Equipment & Supplies
INTUITIVE SURGICAL, INC. ISRG 13,515 $6,318,262.50 2.06% Health Care Equipment & Supplies
CELGENE CORPORATION CELG 67,067 $6,170,164.00 2.01% Biotechnology
AMGEN INC. AMGN 46,216 $6,131,938.88 2.00% Biotechnology
REGENERON PHARMACEUTICALS REGN 17,519 $6,048,960.32 1.97% Biotechnology
BIOGEN IDEC, INC. BIIB 17,304 $5,928,004.32 1.93% Biotechnology
C.R. BARD, INC. BCR 39,015 $5,813,235.00 1.90% Health Care Equipment & Supplies
ZOETIS INC ZTS 166,968 $5,808,816.72 1.89% Pharmaceuticals
HOSPIRA INC HSP 105,571 $5,796,903.61 1.89% Pharmaceuticals
AMERISOURCEBERGEN CORP ABC 74,725 $5,743,363.50 1.87% Health Care Providers & Services
CERNER CORPORATION CERN 101,299 $5,738,081.86 1.87% Health Care Technology
CARDINAL HEALTH, INC. CAH 79,158 $5,737,371.84 1.87% Health Care Providers & Services
ACTAVIS PLC ACT 25,661 $5,731,640.96 1.87% Pharmaceuticals
PERRIGO COMPANY PRGO 38,209 $5,709,570.87 1.86% Pharmaceuticals
BRISTOL MYERS SQUIBB CO BMY 113,901 $5,699,606.04 1.86% Pharmaceuticals
MCKESSON CORPORATION MCK 29,369 $5,685,544.71 1.85% Health Care Providers & Services
ABBOTT LABORATORIES ABT 134,778 $5,679,544.92 1.85% Health Care Equipment & Supplies
WELLPOINT, INC. WLP 50,193 $5,675,322.51 1.85% Health Care Providers & Services
MEDTRONIC, INC. MDT 88,348 $5,667,524.20 1.85% Health Care Equipment & Supplies
QUEST DIAGNOSTICS, INC. DGX 90,578 $5,664,748.12 1.85% Health Care Providers & Services
UNITEDHEALTH GROUP INC. UNH 67,739 $5,651,464.77 1.84% Health Care Providers & Services
ELI LILLY & COMPANY LLY 91,061 $5,646,692.61 1.84% Pharmaceuticals
CAREFUSION CORP CFN 125,535 $5,637,776.85 1.84% Health Care Equipment & Supplies
EXPRESS SCRIPTS HLDGS ESRX 74,913 $5,608,736.31 1.83% Health Care Providers & Services
LABORATORY CORP OF AMERIC LH 52,692 $5,593,255.80 1.82% Health Care Providers & Services
DAVITA, INC DVA 75,773 $5,585,985.56 1.82% Health Care Providers & Services
PATTERSON COS INC PDCO 138,540 $5,555,454.00 1.81% Health Care Providers & Services
CIGNA CORPORATION CI 58,925 $5,536,003.75 1.81% Health Care Providers & Services
ALEXION PHARMACEUTICALS I ALXN 32,754 $5,526,909.96 1.80% Biotechnology
VARIAN MEDICAL SYSTEMS IN VAR 65,535 $5,520,013.05 1.80% Health Care Equipment & Supplies
BAXTER INTERNATIONAL BAX 73,354 $5,519,888.50 1.80% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 45,007 $5,502,555.82 1.79% Life Sciences Tools & Services
MERCK & COMPANY, INC. MRK 92,083 $5,477,096.84 1.79% Pharmaceuticals
ABBVIE INC-W/I ABBV 99,015 $5,451,765.90 1.78% Pharmaceuticals
ALLERGAN INC AGN 33,157 $5,408,901.41 1.76% Pharmaceuticals
JOHNSON & JOHNSON JNJ 52,315 $5,399,431.15 1.76% Pharmaceuticals
BECTON DICKINSON & CO BDX 45,598 $5,364,148.72 1.75% Health Care Equipment & Supplies
AGILENT TECHNOLOGIES, INC A 91,679 $5,347,636.07 1.74% Life Sciences Tools & Services
DENTSPLY INTERNATIONAL XRAY 112,208 $5,335,490.40 1.74% Health Care Equipment & Supplies
ST. JUDE MEDICAL INC. STJ 82,409 $5,301,370.97 1.73% Health Care Equipment & Supplies
HUMANA, INC. HUM 43,018 $5,297,666.70 1.73% Health Care Providers & Services
WATERS CORPORATION WAT 51,133 $5,283,061.56 1.72% Life Sciences Tools & Services
BOSTON SCIENTIFIC CORP BSX 419,006 $5,279,475.60 1.72% Health Care Equipment & Supplies
AETNA INC AET 66,261 $5,268,412.11 1.72% Health Care Providers & Services
STRYKER CORP SYK 64,272 $5,263,234.08 1.72% Health Care Equipment & Supplies
PFIZER INC PFE 181,612 $5,246,770.68 1.71% Pharmaceuticals
PERKINELMER PKI 115,567 $5,217,850.05 1.70% Life Sciences Tools & Services
MYLAN INC. MYL 106,834 $5,191,064.06 1.69% Pharmaceuticals
ZIMMER HOLDINGS INC ZMH 50,811 $5,071,445.91 1.65% Health Care Equipment & Supplies
MALLINCKRODT PLC MNK 66,852 $4,824,708.84 1.57% Pharmaceuticals
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 309,797 $309,796.96 0.10% na

Disclosure

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

2014 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value